PDF herunterladen
Der Nuklearmediziner 2003; 26(2): 114-120
DOI: 10.1055/s-2003-41790
Gastrointestinale Diagnostik

© Georg Thieme Verlag Stuttgart · New York

PET in der Diagnostik des kolorektalen Karzinoms

PET in the Diagnosis of Colorectal CancerS. Dresel1 , F. Rosa1 , B. Scher1
  • 1Klinik und Poliklinik für Nuklearmedizin, Ludwig-Maximilians- Universität, München
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. September 2003 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Die [F-18]FDG-PET ist bei eine Vielzahl onkologischer Applikationen etabliert. Die Primärdiagnostik des kolorektalen Karzinoms ist die Domäne endoskopischer Verfahren. Doch bereits zu diesem Zeitpunkt ist der Einsatz der [F-18]FDG-PET im Rahmen des Stagings sinnvoll, um das therapeutische Vorgehen in Abhängigkeit vom Stadium der Erkrankung zu planen und so ein sinnvolles Patientenmanagement zu ermöglichen. Insbesondere bei Vorhandensein einer Lebermetastasierung ist heute die [F-18]FDG-PET zur Planung einer Resektion der Läsionen mit möglicherweise kurativem Ansatz unverzichtbar. Umgekehrt können mit der [F-18]FDG-PET in Ganzkörpertechnik extrahepatische Herde mit hoher diagnostischer Sicherheit ausgeschlossen oder nachgewiesen werden, um in letzterem Fall unnötige operative Eingriffe zu vermeiden. Für das Restaging hat sich die [F-18 ]FDG-PET zum Nachweis eines Lokalrezidivs als den morphologischen Verfahren überlegen bewährt.

Abstract

[F-18]FDG PET is an established imaging modality in a wide variety of oncologic diseases. The primary diagnosis is usually performed with endoscopic procedures. However, in the pretherapeutic staging [F-18]FDG PET is helpful to clearly stage the patient's disease in order to plan the best therapeutic approach and allow for a correct patient management. Particulary when metastatic disease to the liver is present, [F-18]FDG PET is indispensable for a proper treatment of planning on curative resection. Also with [F-18]FDG PET extrahepatic lesions can be effectively ruled out or confirmed to avoid unnecessary surgery. For restaging in terms of diagnosing local recurrence [F-18]FDG PET has proven to be superior to morphological methods.

Schlüsselwörter

[F-18]FDG-PET - kolorektale Karzinome - Lebermetastasierung

Key words

[F-18]FDG PET - colorectal cancer - liver metastasis

Literatur

  • 1 Abdel-Nabi H, Doerr R J, Lamonica D M, Cronin V R, Galantowicz P J, Carbone G M, Spaulding M B. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.  Radiology. 1998;  206 (3) 755-760
    PubMedGoogle Scholar
  • 2 Balthazar E J. CT of the gastrointestinal tract: principles and interpretation.  AJR Am J Roentgenol. 1991;  156 (1) 23-32
    PubMedGoogle Scholar
  • 3 Beets G, Penninckx F, Schiepers C, Filez L, Mortelmans L, Kerremans R, Aerts R, De Roo M. Clinical value of whole-body positron emission tomography with [18F] fluorodeoxyglucose in recurrent colorectal cancer.  Br J Surg. 1994;  81 (11) 1666-1670
    CrossrefPubMedGoogle Scholar
  • 4 Delbeke D, Patton J A, Martin W H, Sandler M P. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.  J Nucl Med. 1999;  40 (1) 110-117
    PubMedGoogle Scholar
  • 5 Delbeke D, Vitola J V, Sandler M P, Arildsen R C, Powers T A, Wright J K Jr, Chapman W C, Pinson C W. Staging recurrent metastatic colorectal carcinoma with PET.  J Nucl Med. 1997;  38 (8) 1196-1201
    PubMedGoogle Scholar
  • 6 Falk P M, Gupta N C, Thorson A G, Frick M P, Boman B M, Christensen M A, Blatchford G J. Positron emission tomography for preoperative staging of colorectal carcinoma.  Dis Colon Rectum. 1994;  37 (2) 153-156
    PubMedGoogle Scholar
  • 7 Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, Penninckx F, Van Hoe L, Mortelmans L. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.  J Clin Oncol. 1999;  17 (3) 894-901
    PubMedGoogle Scholar
  • 8 Flanagan F L, Dehdashti F, Ogunbiyi O A, Kodner I J, Siegel B A. Utility of FDG PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.  Ann Surg. 1998;  227 (3) 319-323
    CrossrefPubMedGoogle Scholar
  • 9 Fong Y, Cohen A M, Fortner J G, Enker W E, Turnbull A D, Coit D G, Marrero A M, Prasad M, Blumgart L H, Brennan M F. Liver resection for colorectal metastases.  J Clin Oncol. 1997;  15 (3) 938-946
    CrossrefPubMedGoogle Scholar
  • 10 Fong Y, Saldinger P F, Akhurst T, Macapinlac H, Yeung H, Finn R D, Cohen A, Kemeny N, Blumgart L H, Larson S M. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.  Am J Surg. 1999;  178 (4) 282-287
    CrossrefPubMedGoogle Scholar
  • 11 Fortner J G, Silva J S, Golbey R B, Cox E B, Maclean B J. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.  Ann Surg. 1984;  199 (3) 306-316
    PubMedGoogle Scholar
  • 12 Freeny P C, Marks W M, Ryan J A, Bolen J W. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence.  Radiology. 1986;  158 (2) 347-353
    PubMedGoogle Scholar
  • 13 Galandiuk S, Wieand H S, Moertel C G, Cha S S, Fitzgibbons Jr R J, Pemberton J H, Wolff B G. Patterns of recurrence after curative resection of carcinoma of the colon and rectum.  Surg Gynecol Obstet. 1992;  174 (1) 27-32
    PubMedGoogle Scholar
  • 14 Gayowski T J, Iwatsuki S, Madariaga J R, Selby R, Todo S, Irish W, Starzl T E. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.  Surgery. 1994;  116 (4) 703-10; discussion 710-1.
    PubMedGoogle Scholar
  • 15 Greenway B. Hepatic metastases from colorectal cancer: resection or not.  Br J Surg. 1988;  75 (6) 513-519
    PubMedGoogle Scholar
  • 16 Huebner R H, Park K C, Shepherd J E, Schwimmer J, Czernin J, Phelps M E, Gambhir S S. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.  J Nucl Med. 2000;  41 (7) 1177-1189
    PubMedGoogle Scholar
  • 17 Imdahl A, Reinhardt M J, Nitzsche E U, Mix M, Dingeldey A, Einert A, Baier P, Farthmann E H. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.  Langenbecks Arch Surg. 2000;  385 (2) 129-134
    CrossrefPubMedGoogle Scholar
  • 18 Lai D T, Fulham M, Stephen M S, Chu K M, Solomon M, Thompson J F, Sheldon D M, Storey D W. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.  Arch Surg. 1996;  131 (7) 703-707
    PubMedGoogle Scholar
  • 19 Leen E, Angerson W J, Wotherspoon H, Moule B, Cook T G, McArdle C S. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results.  Radiology. 1995;  195 (1) 113-116
    PubMedGoogle Scholar
  • 20 Meta J, Seltzer M, Schiepers C, Silverman D H, Ariannejad M, Gambhir S S, Phelps M E, Valk P, Czernin J. Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.  J Nucl Med. 2001;  42 (4) 586-590
    PubMedGoogle Scholar
  • 21 Moertel C G, Fleming T R, Macdonald J S, Haller D G, Laurie J A, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.  Jama. 1993;  270 (8) 943-947
    CrossrefPubMedGoogle Scholar
  • 22 Moss A A. Imaging of colorectal carcinoma.  Radiology. 1989;  170 (2) 308-310
    PubMedGoogle Scholar
  • 23 Mukai M, Sadahiro S, Yasuda S, Ishida H, Tokunaga N, Tajima T, Makuuchi H. Preoperative evaluation by whole-body 18F- fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer.  Oncol Rep. 2000;  7 (1) 85-87
    PubMedGoogle Scholar
  • 24 Ogunbiyi O A, Flanagan F L, Dehdashti F, Siegel B A, Trask D D, Birnbaum E H, Fleshman J W, Read T E, Philpott G W, Kodner I J. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.  Ann Surg Oncol. 1997;  4 (8) 613-620
    PubMedGoogle Scholar
  • 25 Rigo P, Paulus P, Kaschten B J, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.  Eur J Nucl Med. 1996;  23 (12) 1641-1674
    PubMedGoogle Scholar
  • 26 Ruers T J, Langenhoff B S, Neeleman N, Jager G J, Strijk S, Wobbes T, Corstens F H, Oyen W J. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.  J Clin Oncol. 2002;  20 (2) 388-395
    CrossrefPubMedGoogle Scholar
  • 27 Ruhlmann J, Schomburg A, Bender H, Oehr P, Robertz-Vaupel G M, Vaupel H, Wolter H, Kozak B, Biersack H J. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.  Dis Colon Rectum. 1997;  40 (10) 1195-1204
    PubMedGoogle Scholar
  • 28 Sagar P M, Pemberton J H. Surgical management of locally recurrent rectal cancer.  Br J Surg. 1996;  83 (3) 293-304
    CrossrefPubMedGoogle Scholar
  • 29 Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.  Br J Surg. 1990;  77 (11) 1241-1246
    CrossrefPubMedGoogle Scholar
  • 30 Schiepers C, Penninckx F, De Vadder N, Merckx E, Mortelmans L, Bormans G, Marchal G, Filez L, Aerts R. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging.  Eur J Surg Oncol. 1995;  21 (5) 517-22
    CrossrefPubMedGoogle Scholar
  • 31 Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma.  Br J Surg. 1996;  83 (1) 32-5
    PubMedGoogle Scholar
  • 32 Steele Jr G, Ravikumar T S. Resection of hepatic metastases from colorectal cancer. Biologic perspective.  Ann Surg. 1989;  210 (2) 127-38
    CrossrefPubMedGoogle Scholar
  • 33 Sugarbaker P H. Surgical decision making for large bowel cancer metastatic to the liver.  Radiology. 1990;  174 (3 Pt 1) 621-6
    PubMedGoogle Scholar
  • 34 Takeuchi O, Saito N, Koda K, Sarashina H, Nakajima N. Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer.  Br J Surg. 1999;  86 (7) 932-7
    CrossrefPubMedGoogle Scholar
  • 35 Thoeni R F. Colorectal cancer. Radiologic staging.  Radiol Clin North Am. 1997;  35 (2) 457-85
    PubMedGoogle Scholar
  • 36 Valk P E, Abella-Columna E, Haseman M K, Pounds T R, Tesar R D, Myers R W, Greiss H B, Hofer G A. Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer.  Arch Surg. 1999;  134 (5) 503-511; discussion 511 -513.
    PubMedGoogle Scholar
  • 37 Vauthey J N. Liver imaging. A surgeon's perspective.  Radiol Clin North Am. 1998;  36 (2) 445-457
    Google Scholar
  • 38 Vitola J, Delbeke D. Positron emission tomography for evaluation of colorectal carcinoma.  Semin Roentgenol. 2002;  37 (2) 118-128
    PubMedGoogle Scholar
  • 39 Yonekura Y, Benua R S, Brill A B, Som P, Yeh S D, Kemeny N E, Fowler J S, MacGregor R R, Stamm R, Christman D R, Wolf A P. Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma.  J Nucl Med. 1982;  23 (12) 1133-1137
    PubMedGoogle Scholar

Priv. Doz. Dr. Stefan Dresel

Klinik und Poliklinik für Nuklearmedizin · Ludwig-Maximilians-Universität München · Ziemssenstr. 1

80336 München

Telefon: +49/0 89/51 60-24 43

Fax: +49/0 89/51 60-44 88

eMail: dresel@nuk.med.uni-muenchen.de

      >